The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...
The FDA on Thursday authorized the marketing of 20 ZYN nicotine pouches ... The firm, which has a Sell rating and $105 price target on the shares, says U.S. ZYN is 7% of fiscal 2024 EBIT.
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...